Fatiha Tabet
About Fatiha Tabet
Fatiha Tabet is a Medical Science Liaison in Cardiovascular at Bristol Myers Squibb in Sydney, Australia, with a distinguished background in research and academia.
Current Position at Bristol Myers Squibb
Fatiha Tabet currently holds the position of Medical Science Liaison, Cardiovascular at Bristol Myers Squibb in Sydney, New South Wales, Australia. In her role, she applies her vast science communication and clinical expertise to support the cardiovascular medical affairs team, ensuring the alignment of scientific objectives with stakeholders across the medical and healthcare communities.
Professional Experience at UNSW and University of Sydney
Fatiha Tabet served as a Senior Research Fellow/Senior Lecturer at the University of New South Wales (UNSW) from 2013 to 2019, followed by a Research Fellow and Lecturer position at the University of Sydney from 2007 to 2012. During her tenure at these prestigious institutions, she conducted extensive research, mentored medical and research students, and contributed significantly to the field of medical sciences through academic teaching and industry collaboration.
Academic Background in Pharmacology and Medical Sciences
Fatiha Tabet achieved a Doctor of Philosophy (PhD) in Pharmacology from Université de Montréal, where she also completed her Bachelor's degree in Medical Sciences. Her doctorate, accomplished between 2000 and 2006, and undergraduate studies from 1997 to 2000, laid a strong foundation for her research career, equipping her with critical analytical and scientific skills necessary for her diverse roles in academia and the pharmaceutical industry.
Research Publications and Scholarly Impact
With an impressive record of 34 publications and over 3,200 citations, Fatiha Tabet has made substantial contributions to therapeutic areas such as Cardiology, Endocrinology, Haematology, and Immunology. Her work has been widely recognized within the scientific community, reinforcing her status as an accomplished researcher in these fields.
Clinical Trials and Conference Presentations
Fatiha Tabet was the lead investigator in a subset study of the ILLUMINATE trial (NCT00134264) sponsored by Pfizer Inc., with findings published in the Journal of Clinical Lipidology in 2018. She has delivered over 100 national and international conference presentations, earning more than 20 awards for best presentation or best abstract, including the best presentation award at the International Conference on Lipids and Atherosclerosis in 2018.